References
- Merchant, M. and S.R.Weinberger. 2000. Recent advancements in surface-enhanced laser desorption/ionization-time of flight-mass spectrometry. Electrophoresis21:34–42.
- Fung, E.T., G.L.Wright, and E.A.Dalmasso. 2000. Proteomic strategies for biomarker identification: progress and challenges. Curr. Opin. Mol. Ther.2:643–650.
- Issaq, H.J., T.P.Conrads, D.A.Prieto, R.Tirumalai, and T.D.Veenstra. 2003. SELDI-TOF MS for diagnostic proteomics. Anal. Chem.75:149A–155A.
- Mannes, A.J., B.M.Martin, H.Y.Yang, J.M.Keller, S.Lewin, R.R.Gaiser, and M.J.Iadarola. 2003. Cystatin C as a cerebrospinal fluid biomarker for pain in humans. Pain102:251–256.
- Dare, T.O., H.A.Davies, J.A.Turton, L.Lomas, T.C.Williams, and M.J.York. 2002. Application of surface-enhanced laser desorption/ionization technology to the detection and identification of urinary parvalbumin-α: a biomarker of compound-induced skeletal muscle toxicity in the rat. Electrophoresis23:3241–3251.
- Petricoin, E.F., A.M.Ardekani, B.A.Hitt, P.J.Levine, V.A.Fusaro, S.M.Steinberg, G.B.Mills, C.Simone, et al.. 2002. Use of proteomic patterns in serum to identify ovarian cancer. Lancet359:572–577.
- Beavis, R.C. and B.T.Chait. 1996. Matrix-assisted laser desorption ionization mass-spectrometry of proteins. Methods Enzymol270:519–551.
- Cordingley, H.C., S.L.L.Roberts, P.Tooke, J.R.Armitage, P.W.Lane, W.Wu, and S.E.Wildsmith. 2003. Multifactorial screening design and analysis of SELDI-TOF ProteinChip® array optimization experiments. BioTechniques34:364–373.